Clinical Trials Directory

Trials / Unknown

UnknownNCT01206946

Efficacy of Antenatal Steroids in Reducing Respiratory Morbidities in Late Preterm Infants

Effect of Antenatal Steroids for Women at Risk of Late Preterm Delivery on Neonatal Respiratory Morbidity

Status
Unknown
Phase
Phase 2
Study type
Interventional
Enrollment
700 (estimated)
Sponsor
American University of Beirut Medical Center · Academic / Other
Sex
Female
Age
18 Years – 49 Years
Healthy volunteers
Not accepted

Summary

The hypothesis of the study is that administration of antenatal steroid to women at high risk of preterm birth after 34 weeks of gestation would reduce the risk of respiratory complications, specifically Respiratory Distress Syndrome (RDS) or Transient Tachypnea of the Newborn (TTN) in late preterm babies.

Conditions

Interventions

TypeNameDescription
DRUGBetamethasoneA single course of betamethasone (two doses of 12 mg/dose given at 24 hourly intervals)
OTHERNormal SalineTwo doses of 2ml of normal saline given at 24 hourly intervals

Timeline

Start date
2010-09-01
Primary completion
2013-09-01
Completion
2013-09-01
First posted
2010-09-22
Last updated
2011-06-23

Locations

5 sites across 1 country: Lebanon

Source: ClinicalTrials.gov record NCT01206946. Inclusion in this directory is not an endorsement.